| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 78, 744-752, Copyright © 1994 by Endocrine Society
ARTICLES |
A Juul, P Bang, NT Hertel, K Main, P Dalgaard, K Jorgensen, J Muller, K Hall and NE Skakkebaek
Department of Growth and Reproduction, Rigshospitalet, Copenhagen, Denmark.
Serum levels of insulin-like growth factor-I (IGF-I) increase with age and pubertal development. The large variation in circulating IGF-I levels in adolescence makes it difficult to use the IGF-I value of a single child in the assessment of his growth status. In addition, the interference of IGF-binding proteins in many IGF-I assays contributes to this problem. We measured IGF-I in acid-ethanol-extracted serum from 1030 healthy children, adolescents, and adults, employing a RIA that reduces interference of IGF-binding proteins by using monoiodinated Tyr31-[125I]des-(1-3)IGF-I as radioligand. Mean serum IGF-I concentrations increased slowly in prepubertal children from 80-200 micrograms/L with a further steep increase during puberty to approximately 500 micrograms/L. After puberty, a subsequent continuous fall in circulating IGF-I levels was apparent throughout adulthood to a mean of 100 micrograms/L at the age of 80 yr (P < 0.0001). Girls had maximal IGF-I levels at 14.5 yr of age, whereas boys had peak IGF-I levels 1 yr later. This is almost 2 yr later than average peak height velocity. The large variation in serum IGF-I levels during puberty was diminished when data were separated according to sex and Tanner stage of puberty. Interestingly, we found a significant variation with age within the Tanner stages; there was an increase in serum IGF-I concentrations with age in the early pubertal stages and a decrease in the late stages (P < 0.05). Serum IGF-I increased concomitantly with increasing testicular volume. Multiple regression analysis revealed that serum IGF-I levels predicted height velocity in the following year (r = 0.33; P < 0.0001). Body mass index did not correlate significantly with serum IGF-I in prepubertal children in a multiple regression analysis. In conclusion, there was a significant variation in serum IGF- I levels with age within a given Tanner stage of puberty in addition to the well known increase with increasing age or pubertal stage. Accordingly, the effects of sex, age, and puberty on serum IGF-I cannot be separated into simple additive components when studying 1030 children in a cross-sectional design. Thus, the age-, sex-, and puberty- corrected IGF-I values may, in fact, improve the use of serum IGF-I as a diagnostic tool to distinguish between a child with retarded puberty and a GH-deficient individual.
This article has been cited by other articles:
![]() |
A. W. Roddam, N. E. Allen, P. Appleby, T. J. Key, L. Ferrucci, H. B. Carter, E. J. Metter, C. Chen, N. S. Weiss, A. Fitzpatrick, et al. Insulin-like Growth Factors, Their Binding Proteins, and Prostate Cancer Risk: Analysis of Individual Patient Data from 12 Prospective Studies Ann Intern Med, October 7, 2008; 149(7): 461 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Minami, T. Tochigi, S. Kawamura, H. Tateno, S. Hoshi, Y. Nishino, and M. Kuwahara Height, Urban-born and Prostate Cancer Risk in Japanese Men Jpn. J. Clin. Oncol., March 1, 2008; 38(3): 205 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Aksglaede, N. E. Skakkebaek, and A. Juul Abnormal Sex Chromosome Constitution and Longitudinal Growth: Serum Levels of Insulin-Like Growth Factor (IGF)-I, IGF Binding Protein-3, Luteinizing Hormone, and Testosterone in 109 Males with 47,XXY, 47,XYY, or Sex-Determining Region of the Y Chromosome (SRY)-Positive 46,XX Karyotypes J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 169 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Leger, I. Mercat, C. Alberti, D. Chevenne, P. Armoogum, J. Tichet, and P. Czernichow The relationship between the GH/IGF-I axis and serum markers of bone turnover metabolism in healthy children Eur. J. Endocrinol., November 1, 2007; 157(5): 685 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Waters and J. L. Barclay Does Growth Hormone Drive Breast and Other Cancers? Endocrinology, October 1, 2007; 148(10): 4533 - 4535. [Full Text] [PDF] |
||||
![]() |
E. S Schernhammer, S. S Tworoger, A H. Eliassen, S. A Missmer, J. M Holly, M. N Pollak, and S. E Hankinson Body shape throughout life and correlations with IGFs and GH Endocr. Relat. Cancer, September 1, 2007; 14(3): 721 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sorensen, A. M. Andersson, N. E. Skakkebaek, and A. Juul Serum Sex Hormone-Binding Globulin Levels in Healthy Children and Girls with Precocious Puberty before and during Gonadotropin-Releasing Hormone Agonist Treatment J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3189 - 3196. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Jensen, S. Vielwerth, T. Larsen, G. Greisen, H. Leffers, and A. Juul The Presence of the d3-Growth Hormone Receptor Polymorphism Is Negatively Associated with Fetal Growth but Positively Associated with Postnatal Growth in Healthy Subjects J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2758 - 2763. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Teilmann, M. Boas, J. H. Petersen, K. M. Main, M. Gormsen, K. Damgaard, V. Brocks, N. E. Skakkebaek, and T. K. Jensen Early Pituitary-Gonadal Activation before Clinical Signs of Puberty in 5- to 8-Year-Old Adopted Girls: A Study of 99 Foreign Adopted Girls and 93 Controls J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2538 - 2544. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ekstrom, J. Salemyr, I. Zachrisson, C. Carlsson-Skwirut, E. Ortqvist, and P. Bang Normalization of the IGF-IGFBP Axis by Sustained Nightly Insulinization in Type 1 Diabetes Diabetes Care, June 1, 2007; 30(6): 1357 - 1363. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Parkinson, P. Burman, M. Messig, and P. J. Trainer Gender, Body Weight, Disease Activity, and Previous Radiotherapy Influence the Response to Pegvisomant J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 190 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S.P. Sequoia, M. E. Wright, P. McCarron, P. Pietinen, P. R. Taylor, J. Virtamo, and D. Albanes A Prospective Investigation of Height and Prostate Cancer Risk. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2174 - 2178. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Henderson, M. I. Goran, L. N. Kolonel, B. E. Henderson, and L. Le Marchand Ethnic Disparity in the Relationship between Obesity and Plasma Insulin-Like Growth Factors: The Multiethnic Cohort. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2298 - 2302. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mau Kai, K. M. Main, A. Nyboe Andersen, A. Loft, M. Chellakooty, N. E. Skakkebaek, and A. Juul Serum Insulin-Like Growth Factor-I (IGF-I) and Growth in Children Born after Assisted Reproduction J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4352 - 4360. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sandhu, G. D. Smith, J. Holly, T. J. Cole, and Y. Ben-Shlomo Timing of Puberty Determines Serum Insulin-Like Growth Factor-I in Late Adulthood J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3150 - 3157. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Rogers, C. Metcalfe, D. Gunnell, P. Emmett, D. Dunger, J. Holly, and and the Avon Longitudinal Study of Parents and Chi Insulin-Like Growth Factor-I and Growth in Height, Leg Length, and Trunk Length between Ages 5 and 10 Years J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2514 - 2519. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Bray, D. Gunnell, J. M. P. Holly, N. Middleton, G. D. Smith, and R. M. Martin Associations of Childhood and Adulthood Height and the Components of Height with Insulin-Like Growth Factor Levels in Adulthood: A 65-Year Follow-Up of the Boyd Orr Cohort J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1382 - 1389. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Batty, M. J. Shipley, C. Langenberg, M. G. Marmot, and G. Davey Smith Adult height in relation to mortality from 14 cancer sites in men in London (UK): evidence from the original Whitehall study Ann. Onc., January 1, 2006; 17(1): 157 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W. Parodi Dairy Product Consumption and the Risk of Breast Cancer J. Am. Coll. Nutr., December 1, 2005; 24(suppl_6): 556S - 568S. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Verkauskiene, D. Jaquet, S. Deghmoun, D. Chevenne, P. Czernichow, and C. Levy-Marchal Smallness for Gestational Age Is Associated with Persistent Change in Insulin-Like Growth Factor I (IGF-I) and the Ratio of IGF-I/IGF-Binding Protein-3 in Adulthood J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5672 - 5676. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Rix, P Laurberg, A S Hoejberg, and B Brock-Jacobsen Pegvisomant therapy in pituitary gigantism: successful treatment in a 12-year-old girl Eur. J. Endocrinol., August 1, 2005; 153(2): 195 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Robinson, J. Stevens, M. D. Gammon, and E. M. John Obesity before Age 30 Years and Risk of Advanced Prostate Cancer Am. J. Epidemiol., June 15, 2005; 161(12): 1107 - 1114. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Morimoto, P. A. Newcomb, E. White, J. Bigler, and J. D. Potter Variation in Plasma Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3: Genetic Factors Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1394 - 1401. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Meyerhardt, J. A. Sloan, D. J. Sargent, R. M. Goldberg, M. Pollak, R. F. Morton, R. K. Ramanathan, S. K. Williamson, B. P. Findlay, and C. S. Fuchs Associations between Plasma Insulin-Like Growth Factor Proteins and C-Peptide and Quality of Life in Patients with Metastatic Colorectal Cancer Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1402 - 1410. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Eastell Role of oestrogen in the regulation of bone turnover at the menarche J. Endocrinol., May 1, 2005; 185(2): 223 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ben-Shlomo, J. Holly, A. McCarthy, P. Savage, D. Davies, and G. Davey Smith Prenatal and Postnatal Milk Supplementation and Adult Insulin-like Growth Factor I: Long-term Follow-up of a Randomized Controlled Trial Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1336 - 1339. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tenhola, P. Halonen, J. Jaaskelainen, and R. Voutilainen Serum markers of GH and insulin action in 12-year-old children born small for gestational age Eur. J. Endocrinol., March 1, 2005; 152(3): 335 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lofqvist, E. Andersson, L. Gelander, S. Rosberg, L. Hulthen, W. F. Blum, and K. A. Wikland Reference Values for Insulin-Like Growth Factor-Binding Protein-3 (IGFBP-3) and the Ratio of Insulin-Like Growth Factor-I to IGFBP-3 throughout Childhood and Adolescence J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1420 - 1427. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Healy, R. Dall, J. Gibney, E. Bassett, C. Ehrnborg, C. Pentecost, T. Rosen, A. Cittadini, R. C. Baxter, and P. H. Sonksen Toward the Development of a Test for Growth Hormone (GH) Abuse: A Study of Extreme Physiological Ranges of GH-Dependent Markers in 813 Elite Athletes in the Postcompetition Setting J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 641 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Veldhuis, J. N. Roemmich, E. J. Richmond, A. D. Rogol, J. C. Lovejoy, M. Sheffield-Moore, N. Mauras, and C. Y. Bowers Endocrine Control of Body Composition in Infancy, Childhood, and Puberty Endocr. Rev., February 1, 2005; 26(1): 114 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Fletcher, L. Gibson, N. Johnson, D. R. Altmann, J. M.P. Holly, A. Ashworth, J. Peto, and I. d. S. Silva Polymorphisms and Circulating Levels in the Insulin-Like Growth Factor System and Risk of Breast Cancer: A Systematic Review Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 2 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. MacInnis, D. R. English, D. M. Gertig, J. L. Hopper, and G. G. Giles Body Size and Composition and Risk of Postmenopausal Breast Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2117 - 2125. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Gapstur, P. Kopp, B. C-H. Chiu, P. H. Gann, L. A. Colangelo, and K. Liu Longitudinal Associations of Age, Anthropometric and Lifestyle Factors with Serum Total Insulin-Like Growth Factor-I and IGF Binding Protein-3 Levels in Black and White Men: the CARDIA Male Hormone Study Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2208 - 2216. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Coutant, F. B. de Casson, S. Rouleau, O. Douay, E. Mathieu, F. Gatelais, N. Bouhours-Nouet, C. Voinot, M. Audran, and J. M. Limal Divergent Effect of Endogenous and Exogenous Sex Steroids on the Insulin-Like Growth Factor I Response to Growth Hormone in Short Normal Adolescents J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6185 - 6192. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-C. Leung, G. Johannsson, G. M. Leong, and K. K. Y. Ho Estrogen Regulation of Growth Hormone Action Endocr. Rev., October 1, 2004; 25(5): 693 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. DeLellis, S. Rinaldi, R. J. Kaaks, L. N. Kolonel, B. Henderson, and L. Le Marchand Dietary and Lifestyle Correlates of Plasma Insulin-Like Growth Factor-I (IGF-I) and IGF Binding Protein-3 (IGFBP-3): The Multiethnic Cohort Cancer Epidemiol. Biomarkers Prev., September 1, 2004; 13(9): 1444 - 1451. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hoppe, T. Rovenna Udam, L. Lauritzen, C. Molgaard, A. Juul, and K. Fleischer Michaelsen Animal protein intake, serum insulin-like growth factor I, and growth in healthy 2.5-y-old Danish children Am. J. Clinical Nutrition, August 1, 2004; 80(2): 447 - 452. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Stattin, S. Rinaldi, C. Biessy, U.-H. Stenman, G. Hallmans, and R. Kaaks High Levels of Circulating Insulin-Like Growth Factor-I Increase Prostate Cancer Risk: A Prospective Study in a Population-Based Nonscreened Cohort J. Clin. Oncol., August 1, 2004; 22(15): 3104 - 3112. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Hoffman, J. E. Kuntze, J. Baptista, H. B. A. Baum, G. P. Baumann, B. M. K. Biller, R. V. Clark, D. Cook, S. E. Inzucchi, D. Kleinberg, et al. Growth Hormone (GH) Replacement Therapy in Adult-Onset GH Deficiency: Effects on Body Composition in Men and Women in a Double-Blind, Randomized, Placebo-Controlled Trial J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2048 - 2056. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Fischer-Posovszky, H. Tornqvist, K.-M. Debatin, and M. Wabitsch Inhibition of Death-Receptor Mediated Apoptosis in Human Adipocytes by the Insulin-Like Growth Factor I (IGF-I)/IGF-I Receptor Autocrine Circuit Endocrinology, April 1, 2004; 145(4): 1849 - 1859. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hoppe, C. Molgaard, B. L. Thomsen, A. Juul, and K. F. Michaelsen Protein intake at 9 mo of age is associated with body size but not with body fat in 10-y-old Danish children Am. J. Clinical Nutrition, March 1, 2004; 79(3): 494 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Giovannucci, E. B Rimm, Y. Liu, and W. C Willett Height, predictors of C-peptide and cancer risk in men Int. J. Epidemiol., February 1, 2004; 33(1): 217 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gunnell, S. E. Oliver, J. L. Donovan, T. J. Peters, D. Gillatt, R. Persad, F. C. Hamdy, D. E. Neal, and J. M. P. Holly Do Height-Related Variations in Insulin-Like Growth Factors Underlie the Associations of Stature with Adult Chronic Disease? J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 213 - 218. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chellakooty, K. Vangsgaard, T. Larsen, T. Scheike, J. Falck-Larsen, J. Legarth, A. M. Andersson, K. M. Main, N. E. Skakkebaek, and A. Juul A Longitudinal Study of Intrauterine Growth and the Placental Growth Hormone (GH)-Insulin-Like Growth Factor I Axis in Maternal Circulation: Association between Placental GH and Fetal Growth J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 384 - 391. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lange, U. Feldt-Rasmussen, O. L. Svendsen, K. W. Kastrup, A. Juul, and J. Muller High Risk of Adrenal Insufficiency in Adults Previously Treated for Idiopathic Childhood Onset Growth Hormone Deficiency J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5784 - 5789. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Underwood, K. M. Attie, and J. Baptista Growth Hormone (GH) Dose-Response in Young Adults with Childhood-Onset GH Deficiency: A Two-Year, Multicenter, Multiple-Dose, Placebo-Controlled Study J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5273 - 5280. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Boquete, P. G. V. Sobrado, H. L. Fideleff, A. M. Sequera, A. V. Giaccio, M. G. Suarez, G. F. Ruibal, and M. Miras Evaluation of Diagnostic Accuracy of Insulin-Like Growth Factor (IGF)-I and IGF-Binding Protein-3 in Growth Hormone-Deficient Children and Adults Using ROC Plot Analysis J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4702 - 4708. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Probst-Hensch, H. Wang, V. H. H. Goh, A. Seow, H.-P. Lee, and M. C. Yu Determinants of Circulating Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 3 Concentrations in a Cohort of Singapore Men and Women Cancer Epidemiol. Biomarkers Prev., August 1, 2003; 12(8): 739 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Richiardi, J. Askling, F. Granath, and O. Akre Body Size at Birth and Adulthood and the Risk for Germ-cell Testicular Cancer Cancer Epidemiol. Biomarkers Prev., July 1, 2003; 12(7): 669 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Borofsky, J. H. Vogelman, R. A. Krajcik, and N. Orentreich Utility of Insulin-like Growth Factor-1 as a Biomarker in Epidemiologic Studies Clin. Chem., December 1, 2002; 48(12): 2248 - 2251. [Full Text] [PDF] |
||||
![]() |
C. H. Gravholt, R. W. Naeraa, K. Brixen, K. W. Kastrup, L. Mosekilde, J. O. L. Jorgensen, and J. S. Christiansen Short-Term Growth Hormone Treatment in Girls With Turner Syndrome Decreases Fat Mass and Insulin Sensitivity: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Pediatrics, November 1, 2002; 110(5): 889 - 896. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Swerdlow, B. L. De Stavola, B. Floderus, N. V. Holm, J. Kaprio, P. K. Verkasalo, and T. Mack Risk Factors for Breast Cancer at Young Ages in Twins: An International Population-Based Study J Natl Cancer Inst, August 21, 2002; 94(16): 1238 - 1246. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Juul, T. Scheike, M. Davidsen, J. Gyllenborg, and T. Jorgensen Low Serum Insulin-Like Growth Factor I Is Associated With Increased Risk of Ischemic Heart Disease: A Population-Based Case-Control Study Circulation, August 20, 2002; 106(8): 939 - 944. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. London, J.-M. Yuan, G. S. Travlos, Y.-T. Gao, R. E. Wilson, R. K. Ross, and M. C. Yu Insulin-Like Growth Factor I, IGF-Binding Protein 3, and Lung Cancer Risk in a Prospective Study of Men in China J Natl Cancer Inst, May 15, 2002; 94(10): 749 - 754. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Richards, R. Hardy, D. Kuh, and M. E. Wadsworth Birthweight, postnatal growth and cognitive function in a national UK birth cohort Int. J. Epidemiol., April 1, 2002; 31(2): 342 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ong, J. Kratzsch, W. Kiess, and D. Dunger Circulating IGF-I Levels in Childhood Are Related to Both Current Body Composition and Early Postnatal Growth Rate J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1041 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. W. Lange, J. L. Andersen, N. Beyer, F. Isaksson, B. Larsson, M. H. Rasmussen, A. Juul, J. Bulow, and M. Kjar GH Administration Changes Myosin Heavy Chain Isoforms in Skeletal Muscle But Does Not Augment Muscle Strength or Hypertrophy, Either Alone or Combined with Resistance Exercise Training in Healthy Elderly Men J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 513 - 523. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lofqvist, E. Andersson, L. Gelander, S. Rosberg, W. F. Blum, and K. A. Wikland Reference Values for IGF-I throughout Childhood and Adolescence: A Model that Accounts Simultaneously for the Effect of Gender, Age, and Puberty J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5870 - 5876. [Abstract] [Full Text] [PDF] |
||||
![]() |